The History of Pertussis Toxin

被引:23
|
作者
Locht, Camille [1 ]
Antoine, Rudy [1 ]
机构
[1] Univ Lille, CHU Lille, INSERM, CNRS,Inst Pasteur Lille,U1019,UMR 8204,CIIL, F-59000 Lille, France
关键词
ADP-ribosylation; leukocytosis; histamine sensitization; islet activation; G proteins; pertussis vaccines; ISLET-ACTIVATING PROTEIN; LEUKOCYTOSIS-PROMOTING FACTOR; NAD-GLYCOHYDROLASE ACTIVITY; BORDETELLA-PERTUSSIS; ADP-RIBOSYLATION; PROTECTIVE ANTIGEN; HAEMOPHILUS-PERTUSSIS; INSULIN-SECRETION; ADENYLATE-CYCLASE; SUBUNIT STRUCTURE;
D O I
10.3390/toxins13090623
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Besides the typical whooping cough syndrome, infection with Bordetella pertussis or immunization with whole-cell vaccines can result in a wide variety of physiological manifestations, including leukocytosis, hyper-insulinemia, and histamine sensitization, as well as protection against disease. Initially believed to be associated with different molecular entities, decades of research have provided the demonstration that these activities are all due to a single molecule today referred to as pertussis toxin. The three-dimensional structure and molecular mechanisms of pertussis toxin action, as well as its role in protective immunity have been uncovered in the last 50 years. In this article, we review the history of pertussis toxin, including the paradigm shift that occurred in the 1980s which established the pertussis toxin as a single molecule. We describe the role molecular biology played in the understanding of pertussis toxin action, its role as a molecular tool in cell biology and as a protective antigen in acellular pertussis vaccines and possibly new-generation vaccines, as well as potential therapeutical applications.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] LYMPHOCYTE RECEPTORS FOR PERTUSSIS TOXIN
    CLARK, CG
    ARMSTRONG, GD
    INFECTION AND IMMUNITY, 1990, 58 (12) : 3840 - 3846
  • [22] The ins and outs of pertussis toxin
    Locht, Camille
    Coutte, Loic
    Mielcarek, Nathalie
    FEBS JOURNAL, 2011, 278 (23) : 4668 - 4682
  • [23] PHARMACOLOGICAL ASPECTS OF PERTUSSIS TOXIN
    DEWILDT, DJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (02) : 618 - 619
  • [24] POLYPHOSPHATES ACTIVATE PERTUSSIS TOXIN
    KASLOW, HR
    LIM, LK
    MOSS, J
    JOURNAL OF TOXICOLOGY-TOXIN REVIEWS, 1986, 5 (02): : 191 - 191
  • [25] Pertussis immunity with toxin and addition
    Bullowa, JGM
    Alterman, J
    Katona, N
    Scannell, M
    Robinson, A
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1942, 120 : 886 - 890
  • [26] BINDING OF ATP BY PERTUSSIS TOXIN AND ISOLATED TOXIN SUBUNITS
    HAUSMAN, SZ
    MANCLARK, CR
    BURNS, DL
    BIOCHEMISTRY, 1990, 29 (26) : 6128 - 6131
  • [27] PERTUSSIS TOXIN EXPORT REQUIRES ACCESSORY GENES LOCATED DOWNSTREAM FROM THE PERTUSSIS TOXIN OPERON
    COVACCI, A
    RAPPUOLI, B
    MOLECULAR MICROBIOLOGY, 1993, 8 (03) : 429 - 434
  • [28] Simultaneous Determination of Antibodies to Pertussis Toxin and Adenylate Cyclase Toxin Improves Serological Diagnosis of Pertussis
    Knuutila, Aapo
    Barkoff, Alex-Mikael
    Mertsola, Jussi
    Osicka, Radim
    Sebo, Peter
    He, Qiushui
    DIAGNOSTICS, 2021, 11 (02)
  • [29] DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis
    Stenson, TH
    Weiss, AA
    INFECTION AND IMMUNITY, 2002, 70 (05) : 2297 - 2303
  • [30] Genetic analysis of pertussis toxin promoter activation in Bordetella pertussis
    Marques, RR
    Carbonetti, NH
    MOLECULAR MICROBIOLOGY, 1997, 24 (06) : 1215 - 1224